[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Research Report 2023

December 2023 | 89 pages | ID: G0B09E2A3205EN
QYResearch

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Treatment of ANUG is by removal of dead gum tissue and antibiotics (usually metronidazole) in the acute phase, and improving oral hygiene to prevent recurrence. Although the condition has a rapid onset and is debilitating, it usually resolves quickly and does no serious harm.

According to QYResearch’s new survey, global Necrotizing Ulcerative Gingivitis (NUG) Treatment market is projected to reach US$ 10530 million in 2029, increasing from US$ 6359 million in 2022, with the CAGR of 7.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Necrotizing Ulcerative Gingivitis (NUG) Treatment market research.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Necrotizing Ulcerative Gingivitis (NUG) Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company
  • Novartis
  • Teva Pharmaceutical
  • Mylan
  • Sanofi
  • GlaxoSmithKline
  • Merck
  • Otsuka Pharmaceutical
  • Abbott Laboratories
  • Eli Lilly and Company
  • Hindustan Antibiotics
Segment by Type
  • Medication
  • Surgery
Segment by Application
  • Hospitals
  • Homecare
  • Pharmacies
  • Others
By Region
  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA
The Necrotizing Ulcerative Gingivitis (NUG) Treatment report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)

Chapter 2: Global market size, regional market size. Market Opportunities and Challenges

Chapter 3: Companies’ Competition Patterns

Chapter 4: Product Type Analysis

Chapter 5: Product Application Analysis

Chapter 6 to 10: Country Level Value Analysis

Chapter 11: Companies’ Outline

Chapter 12: Market Conclusions

Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
  1.2.2 Medication
  1.2.3 Surgery
1.3 Market by Application
  1.3.1 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Growth by Application: 2018 VS 2022 VS 2029
  1.3.2 Hospitals
  1.3.3 Homecare
  1.3.4 Pharmacies
  1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Perspective (2018-2029)
2.2 Necrotizing Ulcerative Gingivitis (NUG) Treatment Growth Trends by Region
  2.2.1 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Region: 2018 VS 2022 VS 2029
  2.2.2 Necrotizing Ulcerative Gingivitis (NUG) Treatment Historic Market Size by Region (2018-2023)
  2.2.3 Necrotizing Ulcerative Gingivitis (NUG) Treatment Forecasted Market Size by Region (2024-2029)
2.3 Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Dynamics
  2.3.1 Necrotizing Ulcerative Gingivitis (NUG) Treatment Industry Trends
  2.3.2 Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Drivers
  2.3.3 Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Challenges
  2.3.4 Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Necrotizing Ulcerative Gingivitis (NUG) Treatment Players by Revenue
  3.1.1 Global Top Necrotizing Ulcerative Gingivitis (NUG) Treatment Players by Revenue (2018-2023)
  3.1.2 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue
3.4 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Concentration Ratio
  3.4.1 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue in 2022
3.5 Necrotizing Ulcerative Gingivitis (NUG) Treatment Key Players Head office and Area Served
3.6 Key Players Necrotizing Ulcerative Gingivitis (NUG) Treatment Product Solution and Service
3.7 Date of Enter into Necrotizing Ulcerative Gingivitis (NUG) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 NECROTIZING ULCERATIVE GINGIVITIS (NUG) TREATMENT BREAKDOWN DATA BY TYPE

4.1 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Historic Market Size by Type (2018-2023)
4.2 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Forecasted Market Size by Type (2024-2029)

5 NECROTIZING ULCERATIVE GINGIVITIS (NUG) TREATMENT BREAKDOWN DATA BY APPLICATION

5.1 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Historic Market Size by Application (2018-2023)
5.2 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Forecasted Market Size by Application (2024-2029)

6 NORTH AMERICA

6.1 North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029)
6.2 North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2018-2023)
6.4 North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada

7 EUROPE

7.1 Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029)
7.2 Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2018-2023)
7.4 Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries

8 ASIA-PACIFIC

8.1 Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029)
8.2 Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia

9 LATIN AMERICA

9.1 Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029)
9.2 Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2018-2023)
9.4 Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029)
10.2 Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE

11 KEY PLAYERS PROFILES

11.1 Novartis
  11.1.1 Novartis Company Detail
  11.1.2 Novartis Business Overview
  11.1.3 Novartis Necrotizing Ulcerative Gingivitis (NUG) Treatment Introduction
  11.1.4 Novartis Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2018-2023)
  11.1.5 Novartis Recent Development
11.2 Teva Pharmaceutical
  11.2.1 Teva Pharmaceutical Company Detail
  11.2.2 Teva Pharmaceutical Business Overview
  11.2.3 Teva Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Treatment Introduction
  11.2.4 Teva Pharmaceutical Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2018-2023)
  11.2.5 Teva Pharmaceutical Recent Development
11.3 Mylan
  11.3.1 Mylan Company Detail
  11.3.2 Mylan Business Overview
  11.3.3 Mylan Necrotizing Ulcerative Gingivitis (NUG) Treatment Introduction
  11.3.4 Mylan Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2018-2023)
  11.3.5 Mylan Recent Development
11.4 Sanofi
  11.4.1 Sanofi Company Detail
  11.4.2 Sanofi Business Overview
  11.4.3 Sanofi Necrotizing Ulcerative Gingivitis (NUG) Treatment Introduction
  11.4.4 Sanofi Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2018-2023)
  11.4.5 Sanofi Recent Development
11.5 GlaxoSmithKline
  11.5.1 GlaxoSmithKline Company Detail
  11.5.2 GlaxoSmithKline Business Overview
  11.5.3 GlaxoSmithKline Necrotizing Ulcerative Gingivitis (NUG) Treatment Introduction
  11.5.4 GlaxoSmithKline Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2018-2023)
  11.5.5 GlaxoSmithKline Recent Development
11.6 Merck
  11.6.1 Merck Company Detail
  11.6.2 Merck Business Overview
  11.6.3 Merck Necrotizing Ulcerative Gingivitis (NUG) Treatment Introduction
  11.6.4 Merck Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2018-2023)
  11.6.5 Merck Recent Development
11.7 Otsuka Pharmaceutical
  11.7.1 Otsuka Pharmaceutical Company Detail
  11.7.2 Otsuka Pharmaceutical Business Overview
  11.7.3 Otsuka Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Treatment Introduction
  11.7.4 Otsuka Pharmaceutical Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2018-2023)
  11.7.5 Otsuka Pharmaceutical Recent Development
11.8 Abbott Laboratories
  11.8.1 Abbott Laboratories Company Detail
  11.8.2 Abbott Laboratories Business Overview
  11.8.3 Abbott Laboratories Necrotizing Ulcerative Gingivitis (NUG) Treatment Introduction
  11.8.4 Abbott Laboratories Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2018-2023)
  11.8.5 Abbott Laboratories Recent Development
11.9 Eli Lilly and Company
  11.9.1 Eli Lilly and Company Company Detail
  11.9.2 Eli Lilly and Company Business Overview
  11.9.3 Eli Lilly and Company Necrotizing Ulcerative Gingivitis (NUG) Treatment Introduction
  11.9.4 Eli Lilly and Company Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2018-2023)
  11.9.5 Eli Lilly and Company Recent Development
11.10 Hindustan Antibiotics
  11.10.1 Hindustan Antibiotics Company Detail
  11.10.2 Hindustan Antibiotics Business Overview
  11.10.3 Hindustan Antibiotics Necrotizing Ulcerative Gingivitis (NUG) Treatment Introduction
  11.10.4 Hindustan Antibiotics Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2018-2023)
  11.10.5 Hindustan Antibiotics Recent Development

12 ANALYST'S VIEWPOINTS/CONCLUSIONS


13 APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES

Table 1. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Medication
Table 3. Key Players of Surgery
Table 4. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Region (2018-2023)
Table 8. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Region (2024-2029)
Table 10. Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Trends
Table 11. Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Drivers
Table 12. Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Challenges
Table 13. Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Restraints
Table 14. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Players (2018-2023)
Table 16. Global Top Necrotizing Ulcerative Gingivitis (NUG) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment as of 2022)
Table 17. Ranking of Global Top Necrotizing Ulcerative Gingivitis (NUG) Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Necrotizing Ulcerative Gingivitis (NUG) Treatment Product Solution and Service
Table 21. Date of Enter into Necrotizing Ulcerative Gingivitis (NUG) Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Market Share by Type (2024-2029)
Table 27. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Market Share by Application (2024-2029)
Table 31. North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 46. Novartis Company Detail
Table 47. Novartis Business Overview
Table 48. Novartis Necrotizing Ulcerative Gingivitis (NUG) Treatment Product
Table 49. Novartis Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2018-2023) & (US$ Million)
Table 50. Novartis Recent Development
Table 51. Teva Pharmaceutical Company Detail
Table 52. Teva Pharmaceutical Business Overview
Table 53. Teva Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Treatment Product
Table 54. Teva Pharmaceutical Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2018-2023) & (US$ Million)
Table 55. Teva Pharmaceutical Recent Development
Table 56. Mylan Company Detail
Table 57. Mylan Business Overview
Table 58. Mylan Necrotizing Ulcerative Gingivitis (NUG) Treatment Product
Table 59. Mylan Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2018-2023) & (US$ Million)
Table 60. Mylan Recent Development
Table 61. Sanofi Company Detail
Table 62. Sanofi Business Overview
Table 63. Sanofi Necrotizing Ulcerative Gingivitis (NUG) Treatment Product
Table 64. Sanofi Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2018-2023) & (US$ Million)
Table 65. Sanofi Recent Development
Table 66. GlaxoSmithKline Company Detail
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline Necrotizing Ulcerative Gingivitis (NUG) Treatment Product
Table 69. GlaxoSmithKline Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2018-2023) & (US$ Million)
Table 70. GlaxoSmithKline Recent Development
Table 71. Merck Company Detail
Table 72. Merck Business Overview
Table 73. Merck Necrotizing Ulcerative Gingivitis (NUG) Treatment Product
Table 74. Merck Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2018-2023) & (US$ Million)
Table 75. Merck Recent Development
Table 76. Otsuka Pharmaceutical Company Detail
Table 77. Otsuka Pharmaceutical Business Overview
Table 78. Otsuka Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Treatment Product
Table 79. Otsuka Pharmaceutical Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2018-2023) & (US$ Million)
Table 80. Otsuka Pharmaceutical Recent Development
Table 81. Abbott Laboratories Company Detail
Table 82. Abbott Laboratories Business Overview
Table 83. Abbott Laboratories Necrotizing Ulcerative Gingivitis (NUG) Treatment Product
Table 84. Abbott Laboratories Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2018-2023) & (US$ Million)
Table 85. Abbott Laboratories Recent Development
Table 86. Eli Lilly and Company Company Detail
Table 87. Eli Lilly and Company Business Overview
Table 88. Eli Lilly and Company Necrotizing Ulcerative Gingivitis (NUG) Treatment Product
Table 89. Eli Lilly and Company Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2018-2023) & (US$ Million)
Table 90. Eli Lilly and Company Recent Development
Table 91. Hindustan Antibiotics Company Detail
Table 92. Hindustan Antibiotics Business Overview
Table 93. Hindustan Antibiotics Necrotizing Ulcerative Gingivitis (NUG) Treatment Product
Table 94. Hindustan Antibiotics Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2018-2023) & (US$ Million)
Table 95. Hindustan Antibiotics Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Type: 2022 VS 2029
Figure 3. Medication Features
Figure 4. Surgery Features
Figure 5. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Application: 2022 VS 2029
Figure 7. Hospitals Case Studies
Figure 8. Homecare Case Studies
Figure 9. Pharmacies Case Studies
Figure 10. Others Case Studies
Figure 11. Necrotizing Ulcerative Gingivitis (NUG) Treatment Report Years Considered
Figure 12. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Region: 2022 VS 2029
Figure 15. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Players in 2022
Figure 16. Global Top Necrotizing Ulcerative Gingivitis (NUG) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue in 2022
Figure 18. North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Country (2018-2029)
Figure 20. United States Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Country (2018-2029)
Figure 24. Germany Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Region (2018-2029)
Figure 32. China Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Country (2018-2029)
Figure 40. Mexico Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Country (2018-2029)
Figure 44. Turkey Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Novartis Revenue Growth Rate in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2018-2023)
Figure 47. Teva Pharmaceutical Revenue Growth Rate in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2018-2023)
Figure 48. Mylan Revenue Growth Rate in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2018-2023)
Figure 49. Sanofi Revenue Growth Rate in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2018-2023)
Figure 50. GlaxoSmithKline Revenue Growth Rate in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2018-2023)
Figure 51. Merck Revenue Growth Rate in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2018-2023)
Figure 52. Otsuka Pharmaceutical Revenue Growth Rate in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2018-2023)
Figure 53. Abbott Laboratories Revenue Growth Rate in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2018-2023)
Figure 54. Eli Lilly and Company Revenue Growth Rate in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2018-2023)
Figure 55. Hindustan Antibiotics Revenue Growth Rate in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed


More Publications